1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy ; volume:15 ; number:1 ; day:30 ; month:6 ; year:2015 ; pages:1-7 ; date:12.2015
BMC ophthalmology ; 15, Heft 1 (30.6.2015), 1-7, 12.2015
- Urheber
-
Wong, Ian Y.
- Beteiligte Personen und Organisationen
-
Shi, Xuan
Gangwani, Rita
Zhao, Paul
Iu, Lawrence P.
Li, Qing
Ng, Alex
Li, Xiaoxin
SpringerLink (Online service)
- DOI
-
10.1186/s12886-015-0061-8
- URN
-
urn:nbn:de:1111-2016110916221
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wong, Ian Y.
- Shi, Xuan
- Gangwani, Rita
- Zhao, Paul
- Iu, Lawrence P.
- Li, Qing
- Ng, Alex
- Li, Xiaoxin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Geometric basis of action potential of skeletal muscle cells and neurons
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Die Heilkraft des Waldes – Der Beitrag der Waldmedizin zur Naturtherapie.
Towards multiscale modeling of ocean surface turbulent mixing using coupled MPAS-Ocean v6.3 and PALM v5.0
Towards Multiscale Modeling of Ocean Surface Turbulent Mixing Using Coupled MPAS-Ocean v6.3 and PALM v5.0
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
Geometric basis of action potential of skeletal muscle cells and neurons
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Die Heilkraft des Waldes – Der Beitrag der Waldmedizin zur Naturtherapie.
Towards multiscale modeling of ocean surface turbulent mixing using coupled MPAS-Ocean v6.3 and PALM v5.0
Towards Multiscale Modeling of Ocean Surface Turbulent Mixing Using Coupled MPAS-Ocean v6.3 and PALM v5.0
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
Geometric basis of action potential of skeletal muscle cells and neurons
Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab
Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy
One-Year Outcome of Aflibercept and Photodynamic Therapy in a Caucasian Patient with Polypoidal Choroidal Vasculopathy Refractory to Ranibizumab and Photodynamic Therapy
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
Die Heilkraft des Waldes – Der Beitrag der Waldmedizin zur Naturtherapie.
Towards multiscale modeling of ocean surface turbulent mixing using coupled MPAS-Ocean v6.3 and PALM v5.0
Towards Multiscale Modeling of Ocean Surface Turbulent Mixing Using Coupled MPAS-Ocean v6.3 and PALM v5.0
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort